The C9ORF72 promoter hypermethylation on the other hand, is less common in C9-ALS patients, and is only observed in a fraction (~30%) of individuals with a pathogenic repeat number [13, 15]. This evidence concerns the gene C9 and amyotrophic lateral sclerosis.